Information Contained in EEG Allows Characterization of Cognitive Decline in Neurodegenerative Disorders
Clinical EEG and Neuroscience · 2023-07 · 54 (4) · 391-398
DOI: 10.1177/15500594221120734 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical EEG and Neuroscience, online erschienen am 07.09.2022. Verfasst von Sebastian M Keller und 3 weiteren Autor:innen. Beteiligte Einrichtung: Depts. of Neurology and of Clincial Research, Hospital of the University of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Over the last few decades, electroencephalography (EEG) has evolved from being a method that purely relies on visual inspection into a quantitative method. Quantitative EEG, or QEEG, enables the assessment of neurological disorders based on spectral features, dynamic characterizations of EEG resting-state activity, brain connectivity analyzes or quantification of EEG signal complexity. The information contained in EEG is multidimensional: Electrodes, positioned at different scalp locations, provide a spatial dimension to the analysis of EEG while time provides a dynamic dimension: This multidimensional property of EEG makes its quantification a challenging task. In this narrative review we present quantitative models focused on different aspects of EEG: While microstate models focus more on the quantification of the dynamic aspects of EEG, spectral methods, connectivity analysis and entropy based models are more concerned with its spatial aspects. Nevertheless, these diverse approaches have provided neurophysiology based biomarkers, especially for monitoring and predicting the course of various neurodegenerative disorders. However, their translation into clinical practice crucially depends on the ability to automate the analysis of EEG in a user-friendly manner, without compromising on the validity of the provided results. Once this has been accomplished, EEG would provide an inexpensive and widely available method for monitoring disease progression, identifying patients at risk of neurodegeneration—especially before the onset of clinical symptoms, and predicting future cognition. For stratification of patients to clinical trials, EEG would allow shortening the trial duration and lowering the number of necessary participants by identifying patients at risk of fast cognitive decline.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Depts. of Neurology and of Clincial Research, Hospital of the University of Basel, Basel, Switzerland.
ORCID-Profile: Sebastian M Keller
Zitieren
APA
Keller, S. M., Reyneke, C., Gschwandtner, U., & Fuhr, P. (2023). Information Contained in EEG Allows Characterization of Cognitive Decline in Neurodegenerative Disorders. Clinical EEG and Neuroscience, 54(4), 391-398. https://doi.org/10.1177/15500594221120734
Vancouver
Keller SM, Reyneke C, Gschwandtner U, Fuhr P. Information Contained in EEG Allows Characterization of Cognitive Decline in Neurodegenerative Disorders. Clinical EEG and Neuroscience. 2023;54(4):391-398. doi:10.1177/15500594221120734
BibTeX
@article{Keller2023,
author = {Keller, Sebastian M and Reyneke, Cornelius and Gschwandtner, Ute and Fuhr, Peter},
title = {Information Contained in EEG Allows Characterization of Cognitive Decline in Neurodegenerative Disorders},
journal = {Clinical EEG and Neuroscience},
year = {2023},
volume = {54},
number = {4},
pages = {391--398},
doi = {10.1177/15500594221120734}
}
EUVIMED